Aktie A3EJLK HELIUS MEDICAL TECHNOLOGIES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Helius Medical Technologies, Inc.

Aktien

A3EJLK

US42328V8019

HSDT

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:01 06.05.2024 		% 5 Tage % 1. Jan.
2,42 USD -15,68 % Intraday Chart für Helius Medical Technologies, Inc. -40,83 % -69,90 %
03.05. Top Vorbörsengewinner MT
24.04. Helius Medical Technologies, Inc. erweitert klinisches Schlaganfall-Programm mit Beteiligung des Shepherd Center CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)
Top Premarket Gainers
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
Top Premarket Gainers
Helius Medical Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Helius Medical Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Reports Q4 Revenue $134,000
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
Traders Await Fresh Cues After Powell's Rate-Cut Commentary, Stifling US Equity Futures Pre-Bell
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Earnings Flow Intensifies
Top Premarket Gainers
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EJLK Aktie
  4. Nachrichten Helius Medical Technologies, Inc.
  5. Andere Sprachen